New magnetic resonance imaging methods in nephrology

Kidney International

Volumn 85, Issue 4, 2014, Pages 768-778

  Zhang, Jeff L ^a   Morrell, Glen ^a   Rusinek, Henry ^b   Sigmund, Eric E ^b   Chandarana, Hersh ^b   Lerman, Lilach O ^c   Prasad, Pottumarthi V ^d   Niles, David ^e   Artz, Nathan ^e   Fain, Sean ^e   Vivier, Pierre Hugues ^f   Cheung, Alfred K ^g   Lee, Vivian S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c MAYO CLINIC   (United States)

^d EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^f ROUEN UNIVERSITY HOSPITAL   (France)

^g UNIVERSITY OF UTAH   (United States)

Author keywords

Glomerular filtration rate; Kidney; Magnetic resonance imaging; Perfusion; Tissue oxygenation

Indexed keywords

OXYGEN;

ACUTE KIDNEY FAILURE; ARTERIAL SPIN LABELING; CONTRAST ENHANCEMENT; DIABETIC NEPHROPATHY; DIFFUSION WEIGHTED IMAGING; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; IMAGING AND DISPLAY; KIDNEY GRAFT; KIDNEY TUMOR; NEPHROLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN BLOOD LEVEL; PRIORITY JOURNAL; RENOGRAPHY; RENOVASCULAR DISEASE; REVIEW; PATIENT MONITORING; PEDIATRIC KIDNEY IMAGING; SPIN LABELING; UROGRAPHY; ANIMAL; KIDNEY DISEASES; PROCEDURES; TRENDS;

ANIMALS; HUMANS; KIDNEY DISEASES; MAGNETIC RESONANCE IMAGING; NEPHROLOGY;

EID: 84897410419     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.361     Document Type: Review

References (164)

1. Lee VS, Rusinek H, Johnson G et al. MR renography with low-dose gadopentetate dimeglumine: Feasibility. Radiology 2001; 221: 371-379.
2. Lee VS, Rusinek H, Bokacheva L et al. Renal function measurements from MR renography and a simplified multicompartmental model. Am JPhysiol 2007; 292: F1548-F1559.
3. Prasad PV, Edelman RR, Epstein FH. Noninvasive evaluation of intrarenal oxygenation with BOLD MRI. Circulation 1996; 94: 3271-3275.
4. Textor SC, Glockner JF, Lerman LO et al. The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis. J Am Soc Nephrol 2008; 19: 780-788.
5. Prasad PV. Functional MRI of the kidney: Tools for translational studies of pathophysiology of renal disease. Am J Physiol 2006; 290: F958-F974.
6. Chandarana H, Lee VS. Renal functional MRI: Are we ready for clinical application?. Am J Roentgenol 2009; 192: 1550-1557.
7. Grenier N, Basseau F, Ries M et al. Functional MRI of the kidney. Abdom Imag 2003; 28: 164-175.
8. Kalb B, Martin DR, Salman K et al. Kidney transplantation: Structural and functional evaluation using MR nephro-urography. J Magn Reson Imaging 2008; 28: 805-822.
9. Nikken JJ, Krestin GP. MRI of the kidney-state of the art. Eur Radiol 2007; 17: 2780-2793.
10. Li LP, Halter S, Prasad PV. Blood oxygen level-dependent MR imaging of the kidneys. Magnet Resonan Imag Clin N Am 2008; 16: 613-625.
11. Attenberger UI, Morelli JN, Schoenberg SO et al. Assessment of the kidneys: Magnetic resonance angiography, perfusion and diffusion. J Cardiovasc Magn Reson 2011; 13: 70.
12. Artunc F, Rossi C, Boss A. MRI to assess renal structure and function. Curr Opin Nephrol Hypertens 2011; 20: 669-675.
13. Notohamiprodjo M, Reiser MF, Sourbron SP. Diffusion and perfusion of the kidney. Eur J Radiol 2010; 76: 337-347.
14. Liss P, Cox EF, Eckerbom P et al. Imaging of intrarenal haemodynamics and oxygen metabolism. Clin Exp Pharmacol Physiol 2013; 40: 158-167.
15. Grobner T. Gadolinium-A specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?. Nephrol Dial Transplant 2006; 21: 1104-1108.
16. Leiner T, Kucharczyk W. NSF prevention in clinical practice: Summary of recommendations and guidelines in the United States, Canada, and Europe. J Magn Reson Imaging 2009; 30: 1357-1363.
17. Thomsen HS. ESUR guideline: Gadolinium-based contrast media and nephrogenic systemic fibrosis. Eur Radiol 2007; 17: 2692-2696.
18. Wang Y, Alkasab TK, Narin O et al. Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines. Radiology 2011; 260: 105-111.
19. Bokacheva L, Rusinek H, Chen Q et al. Quantitative determination of Gd-DTPA concentration in T(1)-weighted MR renography studies. Magn Reson Med 2007; 57: 1012-1018.
20. Donahue KM, Weisskoff RM, Burstein D. Water diffusion and exchange as they influence contrast enhancement. J Magn Reson Imaging 1997; 7: 102-110.
21. Zhang JL, Rusinek H, Bokacheva L et al. Functional assessment of the kidney from magnetic resonance and computed tomography renography: Impulse retention approach to a multicompartment model. Magn Reson Med 2008; 59: 278-288.
22. Sourbron SP, Michaely HJ, Reiser MF et al. MRI-measurement of perfusion and glomerular filtration in the human kidney with a separable compartment model. Invest Radiol 2008; 43: 40-48.
23. Buckley DL, Shurrab AE, Cheung CM et al. Measurement of single kidney function using dynamic contrast-enhanced MRI: Comparison of two models in human subjects. J Magn Reson Imaging 2006; 24: 1117-1123.
24. Bokacheva L, Rusinek H, Zhang JL et al. Estimates of glomerular filtration rate from MR renography and tracer kinetic models. J Magn Reson Imaging 2009; 29: 371-382.
25. Tofts PS, Cutajar M, Mendichovszky IA et al. Precise measurement of renal filtration and vascular parameters using a two-compartment model for dynamic contrast-enhanced MRI of the kidney gives realistic normal values. Eur Radiol 2012; 22: 1320-1330.
26. Hackstein N, Kooijman H, Tomaselli S et al. Glomerular filtration rate measured using the Patlak plot technique and contrast-enhanced dynamic MRI with different amounts of gadolinium-DTPA. J Magn Reson Imaging 2005; 22: 406-414.
27. Cutajar M, Mendichovszky IA, Tofts PS et al. The importance of AIF ROI selection in DCE-MRI renography: Reproducibility and variability of renal perfusion and filtration. Eur J Radiol 2010; 74: E154-e160.
28. Zhang JL, Rusinek H, Bokacheva L et al. Use of cardiac output to improve measurement of input function in quantitative dynamic contrastenhanced MRI. J Magn Reson Imaging 2009; 30: 656-665.
29. Park JB, Hu BS, Conolly SM et al. Rapid cardiac-output measurement with ungated spiral phase contrast. Magn Reson Med 2006; 56: 432-438.
30. Yamamoto A, Zhang JL, Rusinek H et al. Quantitative evaluation of acute renal transplant dysfunction with low-dose three-dimensional MR renography. Radiology 2011; 260: 781-789.
31. Khrichenko D, Darge K. Functional analysis in MR urography-made simple. Pediatr Radiol 2010; 40: 182-199.
32. Vivier PH, Dolores M, Taylor M et al. MR urography in children. Part 2: How to use ImageJ MR urography processing software. Pediatr Radiol 2010; 40: 739-746.
33. Mikheev A, Lee VS, Rusinek H. Targeted coregistration of abdominal DCE MRI. Proceedings of the 19th Annual Meeting of ISMRM. Montreal, Canada, 2011; p2595.
34. Rusinek H, Boykov Y, Kaur M et al. Performance of an automated segmentation algorithm for 3D MR renography. Magn Reson Med 2007; 57: 1159-1167.
35. Ogawa S, Lee TM, Kay AR et al. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci USA 1990; 87: 9868-9872.
36. Brezis M, Agmon Y, Epstein FH. Determinants of intrarenal oxygenation. I. Effects of diuretics. Am J Physiol 1994; 267: F1059-F1062.
37. Warner L, Glockner JF, Woollard J et al. Determinations of renal cortical and medullary oxygenation using blood oxygen level-dependent magnetic resonance imaging and selective diuretics. Invest Radiol 2011; 46: 41-47.
38. Priatna A, Epstein FH, Spokes K et al. Evaluation of changes in intrarenal oxygenation in rats using multiple gradient-recalled echo (mGRE) sequence. J Magn Reson Imaging 1999; 9: 842-846.
39. Economides PA, Caselli A, Zuo CS et al. Kidney oxygenation during water diuresis and endothelial function in patients with type 2 diabetes and subjects at risk to develop diabetes. Metabolism 2004; 53: 222-227.
40. Epstein FH, Veves A, Prasad PV. Effect of diabetes on renal medullary oxygenation during water diuresis. Diabetes Care 2002; 25: 575-578.
41. Epstein FH, Prasad P. Effects of furosemide on medullary oxygenation in younger and older subjects. Kidney Int 2000; 57: 2080-2083.
42. Yin WJ, Liu F, Li XM et al. Noninvasive evaluation of renal oxygenation in diabetic nephropathy by BOLD-MRI. Eur J Radiol 2012; 81: 1426-1431.
43. dos Santos EA, Li LP, Ji L et al. Early changes with diabetes in renal medullary hemodynamics as evaluated by fiberoptic probes and BOLD magnetic resonance imaging. Invest Radiol 2007; 42: 157-162.
44. Fine LG, Bandyopadhay D, Norman JT. Is there a common mechanism for the progression of different types of renal diseases other than proteinuria?. Towards the unifying theme of chronic hypoxia. Kidney Int Suppl 2000; 75: S22-S26.
45. Fine LG, Norman JT. Chronic hypoxia as a mechanism of progression of chronic kidney diseases: From hypothesis to novel therapeutics. Kidney Int 2008; 74: 867-872.
46. Nangaku M. Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure. J Am Soc Nephrol 2006; 17: 17-25.
47. Michaely HJ, Metzger L, Haneder S et al. Renal BOLD-MRI does not reflect renal function in chronic kidney disease. Kidney Int 2012; 81: 684-689.
48. Ries M, Basseau F, Tyndal B et al. Renal diffusion and BOLD MRI in experimental diabetic nephropathy. Blood oxygen level-dependent. J Magn Reson Imaging 2003; 17: 104-113.
49. Morrell G, Jeong EK, Shi X et al. Prospectively Navigated Multi-Echo GRE Sequence for Improved 2D BOLD Imaging of the Kidneys. Proceedings of the 21th Annual Meeting of ISMRM Salt Lake City, UT, USA, 2013; p 1569.
50. Zhang JL, Warner L, Rusinek H et al. Establishment of a Renal Oxygen Transit Model Based on BOLD MRI. Proceedings of the 19th Annual Meeting of ISMRM Montreal, Canada, 2011; p 442.
51. Zhang JL, H R, H C et al. Functional Renal Imaging with BOLD: Validation of a Model for R2 in Kidney Cortex and Medulla. Proceedings of the 18th Annual Meeting of ISMRM Stockholm, Sweden, 2010; p 4681.
52. Glover GH. 3D z-shim method for reduction of susceptibility effects in BOLD fMRI. Magn Reson Med 1999; 42: 290-299.
53. Detre JA, Leigh JS, Williams DS et al. Perfusion imaging. Magn Reson Med 1992; 23: 37-45.
54. Williams DS, Detre JA, Leigh JS et al. Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci USA 1992; 89: 212-216.
55. Martirosian P, Klose U, Mader I et al. FAIR true-FISP perfusion imaging of the kidneys. Magn Reson Med 2004; 51: 353-361.
56. Grossman EJ, Zhang K, An J et al. Measurement of deep gray matter perfusion using a segmented true-fast imaging with steady-state precession (True-FISP) arterial spin-labeling (ASL) method at 3T. J Magn Reson Imaging 2009; 29: 1425-1431.
57. Marckmann P, Skov L, Rossen K et al. Nephrogenic systemic fibrosis: Suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006; 17: 2359-2362.
58. Sadowski EA, Bennett LK, Chan MR et al. Nephrogenic systemic fibrosis: Risk factors and incidence estimation. Radiology 2007; 243: 148-157.
59. Kuo PH, Kanal E, Abu-Alfa AK et al. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 2007; 242: 647-649.
60. Artz NS, Sadowski EA, Wentland AL et al. Arterial spin labeling MRI for assessment of perfusion in native and transplanted kidneys. Magn Reson Imaging 2011; 29: 74-82.
61. Robson PM, Madhuranthakam AJ, Dai W et al. Strategies for reducing respiratory motion artifacts in renal perfusion imaging with arterial spin labeling. Magn Reson Med 2009; 61: 1374-1387.
62. Tan H, Koktzoglou I, Prasad PV. Renal perfusion imaging with twodimensional navigator gated arterial spin labeling. Magn Reson Med 2013 (e-pub ahead of print).
63. Gardener AG, Francis ST. Multislice perfusion of the kidneys using parallel imaging: Image acquisition and analysis strategies. Magn Reson Med 2010; 63: 1627-1636.
64. Artz NS, Sadowski EA, Wentland AL et al. Reproducibility of renal perfusion MR imaging in native and transplanted kidneys using non-contrast arterial spin labeling. J Magn Reson Imaging 2011; 33: 1414-1421.
65. Artz NS, Wentland AL, Sadowski EA et al. Comparing kidney perfusion using noncontrast arterial spin labeling MRI and microsphere methods in an interventional swine model. Invest Radiol 2011; 46: 124-131.
66. Boss A, Martirosian P, Graf H et al. High resolution MR perfusion imaging of the kidneys at 3 Tesla without administration of contrast media. Rofo 2005; 177: 1625-1630.
67. de Bazelaire C, Alsop DC, George D et al. Magnetic resonance imagingmeasured blood flow change after antiangiogenic therapy with PTK787/ZK 222584 correlates with clinical outcome in metastatic renal cell carcinoma. Clin Cancer Res 2008; 14: 5548-5554.
68. De Bazelaire C, Rofsky NM, Duhamel G et al. Arterial spin labeling blood flow magnetic resonance imaging for the characterization of metastatic renal cell carcinoma(1). Acad Radiol 2005; 12: 347-357.
69. Fenchel M, Martirosian P, Langanke J et al. Perfusion MR imaging with FAIR true FISP spin labeling in patients with and without renal artery stenosis: Initial experience. Radiology 2006; 238: 1013-1021.
70. Heusch P, Wittsack HJ, Heusner T et al. Correlation of biexponential diffusion parameters with arterial spin-labeling perfusion MRI: Results in transplanted kidneys. Invest Radiol 2013; 48: 140-144.
71. Karger N, Biederer J, Lusse S et al. Quantitation of renal perfusion using arterial spin labeling with FAIR-UFLARE. Magn Reson Imaging 2000; 18: 641-647.
72. Lanzman RS, Robson PM, Sun MR et al. Arterial spin-labeling MR imaging of renal masses: Correlation with histopathologic findings. Radiology 2012; 265: 799-808.
73. Lanzman RS, Wittsack HJ, Martirosian P et al. Quantification of renal allograft perfusion using arterial spin labeling MRI: Initial results. Eur Radiol 2009; 20: 1485-1491.
74. Michaely HJ, Schoenberg SO, Ittrich C et al. Renal disease: Value of functional magnetic resonance imaging with flow and perfusion measurements. Invest Radiol 2004; 39: 698-705.
75. Pedrosa I, Rafatzand K, Robson P et al. Arterial spin labeling MR imaging for characterisation of renal masses in patients with impaired renal function: Initial experience. Eur Radiol 2012; 22: 484-492.
76. Ritt M, Janka R, Schneider MP et al. Measurement of kidney perfusion by magnetic resonance imaging: Comparison of MRI with arterial spin labeling to para-Aminohippuric acid plasma clearance in male subjects with metabolic syndrome. Nephrol Dial Transplant 2009; 25: 1126-1133.
77. Roberts DA, Detre JA, Bolinger L et al. Renal perfusion in humans: MR imaging with spin tagging of arterial water. Radiology 1995; 196: 281-286.
78. Rossi C, Artunc F, Martirosian P et al. Histogram analysis of renal arterial spin labeling perfusion data reveals differences between volunteers and patients with mild chronic kidney disease. Invest Radiol 2012; 47: 490-496.
79. Sugimori H, Nakanishi M, Fujima N et al. Evaluation of renal blood flow using multi-phase echo-planar magnetic resonance imaging and signal targeting with alternating radiofrequency (EPISTAR) in 3-T magnetic resonance imaging. Radiol Phys Technol 2013; 6: 86-91.
80. Wu WC, Su MY, Chang CC et al. Renal perfusion 3-T MR imaging: A comparative study of arterial spin labeling and dynamic contrastenhanced techniques. Radiology 2011; 261: 845-853.
81. Petersen ET, Zimine I, Ho YC et al. Non-invasive measurement of perfusion: A critical review of arterial spin labelling techniques. Br J Radiol 2006; 79: 688-701.
82. Wu WC, Fernandez-Seara M, Detre JA et al. A theoretical and experimental investigation of the tagging efficiency of pseudocontinuous arterial spin labeling. Magn Reson Med 2007; 58: 1020-1027.
83. Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-Tensor MRI. J Magn Resonan Ser B 1996; 111: 209-219.
84. Basser PJ, Mattiello J, Lebihan D. Mr diffusion tensor spectroscopy and imaging. Biophys J 1994; 66: 259-267.
85. Gurses B, Kilickesmez O, Tasdelen N et al. Diffusion tensor imaging of the kidney at 3 Tesla MRI: Normative values and repeatability of measurements in healthy volunteers. Diagn Interven Radiol (Ankara, Turkey) 2011; 17: 317-322.
86. Kido A, Kataoka M, Yamamoto A et al. Diffusion tensor MRI of the kidney at 3.0 and 1.5 Tesla. Acta Radiol 2010; 51: 1059-1063.
87. Lebihan D, Breton E, Lallemand D et al. Separation of diffusion and perfusion in intravoxel incoherent motion Mr imaging. Radiology 1988; 168: 497-505.
88. Xu Y, Wang X, Jiang X. Relationship between the renal apparent diffusion coefficient and glomerular filtration rate: Preliminary experience. J Magn Reson Imaging 2007; 26: 678-681.
89. Sigmund EE, Jensen JH. Basic physical principles of body diffusionweighted imaging. In: Taouli B (ed). Extra-Cranial Applications of Diffusion-Weighted MRI. Cambridge University Press, 2011, pp 1-17.
90. Thoeny HC, De Keyzer F, Oyen RH et al. Diffusion-weighted MR imaging of kidneys in healthy volunteers and patients with parenchymal diseases: Initial experience. Radiology 2005; 235: 911-917.
91. Sigmund EE, Vivier PH, Sui D et al. Intravoxel incoherent motion and diffusion-Tensor imaging in renal tissue under hydration and furosemide flow challenges. Radiology 2012; 263: 758-769.
92. Lee VS, Rofsky NM, Krinsky GA et al. Single-dose breath-hold gadolinium-enhanced three-dimensional MR angiography of the renal arteries. Radiology 1999; 211: 69-78.
93. Miyazaki M, Lee VS, Nonenhanced MR. angiography. Radiology 2008; 248: 20-43.
94. Prince MR, Schoenberg SO, Ward JS et al. Hemodynamically significant atherosclerotic renal artery stenosis: MR angiographic features. Radiology 1997; 205: 128-136.
95. Schoenberg SO, Aumann S, Just A et al. Quantification of renal perfusion abnormalities using an intravascular contrast agent (part 2): Results in animals and humans with renal artery stenosis. Magn Reson Med 2003; 49: 288-298.
96. Schoenberg SO, Rieger JR, Michaely HJ et al. Functional magnetic resonance imaging in renal artery stenosis. Abdom Imag 2006; 31: 200-212.
97. Prasad PV, Goldfarb J, Sundaram C et al. Captopril MR renography in a swine model: Toward a comprehensive evaluation of renal arterial stenosis. Radiology 2000; 217: 813-818.
98. Zhang JL, Rusinek H, Bokacheva L et al. Angiotensin-converting enzyme inhibitor-enhanced MR renography: Repeated measures of GFR and RPF in hypertensive patients. Am J Physiol 2009; 296: F884-F891.
99. Gloviczki ML, Glockner JF, Lerman LO et al. Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis. Hypertension 2010; 55: 961-966.
100. Gloviczki ML, Glockner JF, Crane JA et al. Blood oxygen level-dependent magnetic resonance imaging identifies cortical hypoxia in severe renovascular disease. Hypertension 2011; 58: 1066-1072.
101. Ebrahimi B, Gloviczki M, Woollard JR et al. Compartmental analysis of renal BOLD MRI data: Introduction and validation. Invest Radiol 2012; 47: 175-182.
102. Gloviczki ML, Keddis MT, Garovic VD et al. TGF expression and macrophage accumulation in atherosclerotic renal artery stenosis. Clin J Am Soc Nephrol 2012; 8: 546-553.
103. Textor SC, Gloviczki ML, Flessner MF et al. Association of filtered sodium load with medullary volumes and medullary hypoxia in hypertensive African Americans as compared with whites. Am J Kidney Dis 2012; 59: 229-237.
104. Eirin A, Ebrahimi B, Zhang X et al. Changes in glomerular filtration rate after renal revascularization correlate with microvascular hemodynamics and inflammation in Swine renal artery stenosis. Circ Cardiovasc Interv 2012; 5: 720-728.
105. Warner L, Yin M, Glaser KJ et al. Noninvasive in vivo assessment of renal tissue elasticity during graded renal ischemia Using MR elastography. Invest Radiol 2011; 46: 509-514.
106. Korsmo MJ, Ebrahimi B, Eirin A et al. Magnetic resonance elastography noninvasively detects in vivo renal medullary fibrosis secondary to Swine renal artery stenosis. Invest Radiol 2013; 48: 61-68.
107. Yildirim E, Kirbas I, Teksam M et al. Diffusion-weighted MR imaging of kidneys in renal artery stenosis. Eur J Radiol 2008; 65: 148-153.
108. Yildirim E, Gullu H, Caliskan M et al. The effect of hypertension on the apparent diffusion coefficient values of kidneys. Diagn Interven Radiol (Ankara, Turkey) 2008; 14: 9-13.
109. Murphy TP, Cooper CJ, Dworkin LD et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: Rationale and methods. J Vasc Interv Radiol 2005; 16: 1295-1300.
110. Fine LG, Norman JT. Chronic hypoxia as a mechanism of progression of chronic kidney diseases: From hypothesis to novel therapeutics. Kidney Int 2008; 74: 867-872.
111. Wang ZJ, Kumar R, Banerjee S et al. Blood oxygen level-dependent (BOLD) MRI of diabetic nephropathy: Preliminary experience. J Magn Reson Imaging 2011; 33: 655-660.
112. Yin WJ, Liu F, Li XM et al. Noninvasive evaluation of renal oxygenation in diabetic nephropathy by BOLD-MRI. Eur J Radiol 2012; 81: 1426-1431.
113. Hueper K, Hartung D, Gutberlet M et al. Magnetic resonance diffusion tensor imaging for evaluation of histopathological changes in a rat model of diabetic nephropathy. Invest Radiol 2012; 47: 430-437.
114. Lu L, Sedor JR, Gulani V et al. Use of diffusion tensor MRI to identify early changes in diabetic nephropathy. Am J Nephrol 2011; 34: 476-482.
115. Inoue T, Kozawa E, Okada H et al. Noninvasive evaluation of kidney hypoxia and fibrosis using magnetic resonance imaging. J Am Soc Nephrol 2011; 22: 1429-1434.
116. Ries M, Basseau F, Tyndal B et al. Renal diffusion and BOLD MRI in experimental diabetic nephropathy. Blood oxygen level-dependent. J Magn Resonan Imaging 2003; 17: 104-113.
117. dos Santos EA, Li LP, Ji L et al. Early changes with diabetes in renal medullary hemodynamics as evaluated by fiberoptic probes and BOLD magnetic resonance imaging. Invest Radiol 2007; 42: 157-162.
118. Prasad P, Li LP, Halter S et al. Evaluation of renal hypoxia in diabetic mice by BOLD MRI. Invest Radiol 2010; 45: 819-822.
119. Togao O, Doi S, Kuro-o M et al. Assessment of renal fibrosis with diffusion-weighted MR imaging: Study with murine model of unilateral ureteral obstruction. Radiology 2010; 255: 772-780.
120. Pruijm M, Hofmann L, Zanchi A et al. Blockade of the renin-Angiotensin system and renal tissue oxygenation as measured with BOLD-MRI in patients with type 2 diabetes. Diabetes Res Clin Pract 2012; 99: 136-144.
121. Szolar DH, Preidler K, Ebner F et al. Functional magnetic resonance imaging of human renal allografts during the post-Transplant period: Preliminary observations. Magn Reson Imaging 1997; 15: 727-735.
122. Wentland AL, Sadowski EA, Djamali A et al. Quantitative MR measures of intrarenal perfusion in the assessment of transplanted kidneys: Initial experience. Acad Radiol 2009; 16: 1077-1085.
123. Sadowski EA, Fain SB, Alford SK et al. Assessment of acute renal transplant rejection with blood oxygen level-dependent MR imaging: Initial experience. Radiology 2005; 236: 911-919.
124. Han F, Xiao W, Xu Y et al. The significance of BOLD MRI in differentiation between renal transplant rejection and acute tubular necrosis. Nephrol Dial Transplant 2008; 23: 2666-2672.
125. Djamali A, Sadowski EA, Muehrer RJ et al. BOLD-MRI assessment of intrarenal oxygenation and oxidative stress in patients with chronic kidney allograft dysfunction. Am J Physiol 2007; 292: F513-F522.
126. Vermathen P, Binser T, Boesch C et al. Three-year follow-up of human transplanted kidneys by diffusion-weighted MRI and blood oxygenation level-dependent imaging. J Magn Reson Imaging 2012; 35: 1133-1138.
127. Malvezzi P, Bricault I, Terrier N et al. Evaluation of intrarenal oxygenation by blood oxygen level-dependent magnetic resonance imaging in living kidney donors and their recipients: Preliminary results. Transplant Proc 2009; 41: 641-644.
128. Niles DJ, Artz NS, Sadowski E et al. Longitudinal measurement of renal oxygenation and perfusion in donor-recipient pairs using BOLD and ASL MRI. Proceedings of the 20th Annual Meeting of ISMRM Melbourne, Australia, 2012.
129. Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology 1998; 51: 203-205.
130. Chow WH, Devesa SS, Warren JL et al. Rising incidence of renal cell cancer in the United States. JAMA 1999; 281: 1628-1631.
131. Lam JS, Shvarts O, Leppert JT et al. Renal cell carcinoma 2005: New frontiers in staging, prognostication and targeted molecular therapy. J Urol 2005; 173: 1853-1862.
132. Cheville JC, Lohse CM, Zincke H et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003; 27: 612-624.
133. Ho VB, Allen SF, Hood MN et al. Renal masses: Quantitative assessment of enhancement with dynamic MR imaging. Radiology 2002; 224: 695-700.
134. Hecht EM, Israel GM, Krinsky GA et al. Renal masses: Quantitative analysis of enhancement with signal intensity measurements versus. qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging. Radiology 2004; 232: 373-378.
135. Sun MR, Ngo L, Genega EM et al. Renal cell carcinoma: Dynamic contrastenhanced MR imaging for differentiation of tumor subtypes-correlation with pathologic findings. Radiology 2009; 250: 793-802.
136. Chandarana H, Rosenkrantz AB, Mussi TC et al. Histogram analysis of whole-lesion enhancement in differentiating clear cell from papillary subtype of renal cell cancer. Radiology 2012; 265: 790-798.
137. Scialpi M, Di Maggio A, Midiri M et al. Small renal masses: Assessment of lesion characterization and vascularity on dynamic contrast-enhanced MR imaging with fat suppression. Am J Roentgenol 2000; 175: 751-757.
138. Notohamiprodjo M, Sourbron S, Staehler M et al. Measuring perfusion and permeability in renal cell carcinoma with dynamic contrastenhanced MRI: A pilot study. J Magn Reson Imaging 2010; 31: 490-501.
139. Cova M, Squillaci E, Stacul F et al. Diffusion-weighted MRI in the evaluation of renal lesions: Preliminary results. Br J Radiol 2004; 77: 851-857.
140. Taouli B, Thakur RK, Mannelli L et al. Renal lesions: Characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. Radiology 2009; 251: 398-407.
141. Zhang J, Tehrani YM, Wang L et al. Renal masses: Characterization with diffusion-weighted MR imaging-A preliminary experience. Radiology 2008; 247: 458-464.
142. Kim S, Jain M, Harris AB et al. T1 hyperintense renal lesions: Characterization with diffusion-weighted MR imaging versus contrastenhanced MR imaging. Radiology 2009; 251: 796-807.
143. Sandrasegaran K, Sundaram CP, Ramaswamy R et al. Usefulness of diffusion-weighted imaging in the evaluation of renal masses. Am J Roentgenol 2010; 194: 438-445.
144. Wang H, Cheng L, Zhang X et al. Renal cell carcinoma: Diffusionweighted MR imaging for subtype differentiation at 3.0 T. Radiology 2010; 257: 135-143.
145. Rosenkrantz AB, Niver BE, Fitzgerald EF et al. Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade. Am J Roentgenol 2010; 195: W344-W351.
146. Chandarana H, Lee VS, Hecht E et al. Comparison of biexponential and monoexponential model of diffusion weighted imaging in evaluation of renal lesions: Preliminary experience. Invest Radiol 2011; 46: 285-291.
147. Chandarana H, Kang SK, Wong S et al. Diffusion-weighted intravoxel incoherent motion imaging of renal tumors with histopathologic correlation. Invest Radiol 2012; 47: 688-696.
148. Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet 2012; 380: 756-766.
149. Kellum JA, Bellomo R, Ronco C. The concept of acute kidney injury and the RIFLE criteria. Contrib Nephrol 2007; 156: 10-16.
150. Palevsky PM. Chronic-on-Acute kidney injury. Kidney Int 2012; 81: 430-431.
151. Coca SG, Cho KC, Hsu CY. Acute kidney injury in the elderly: Predisposition to chronic kidney disease and vice versa. Nephron Clin Pract 2011; 119(Suppl 1): C19-c24.
152. He X, Aghayev A, Gumus S et al. Estimation of single-kidney glomerular filtration rate without exogenous contrast agent. Magn Reson Med 2013 (e-pub ahead of print).
153. Zimmer F, Zollner FG, Hoeger S et al. Quantitative renal perfusion measurements in a rat model of acute kidney injury at 3T: Testing inter-And intramethodical significance of ASL and DCE-MRI. PLoS One 2013; 8: E53849.
154. Prowle JR, Molan MP, Hornsey E et al. Measurement of renal blood flow by phase-contrast magnetic resonance imaging during septic acute kidney injury: A pilot investigation. Crit Care Med 2012; 40: 1768-1776.
155. Singh P, Ricksten SE, Bragadottir G et al. Renal oxygenation and haemodynamics in acute kidney injury and chronic kidney disease. Clin Exp Pharmacol Physiol 2013; 40: 138-147.
156. Rosen S, Epstein FH, Brezis M. Determinants of intrarenal oxygenation: Factors in acute renal failure. Renal Fail 1992; 14: 321-325.
157. Li LP, Franklin T, Du H et al. Intrarenal oxygenation by blood oxygenation level-dependent MRI in contrast nephropathy model: Effect of the viscosity and dose. J Magn Reson Imaging 2012; 36: 1162-1167.
158. Koff SA. Requirements for accurately diagnosing chronic partial upper urinary tract obstruction in children with hydronephrosis. Pediatr Radiol 2008; 38(Suppl 1): S41-S48.
159. Grattan-Smith JD, Perez-Bayfield MR, Jones RA et al. MR imaging of kidneys: Functional evaluation using F-15 perfusion imaging. Pediatr Radiol 2003; 33: 293-304.
160. Vivier PH, Dolores M, Taylor M et al. MR urography in children. Part 1: How we do the F0 technique. Pediatr Radiol 2010; 40: 732-738.
161. Jones RA, Schmotzer B, Little SB et al. MRU post-processing. Pediatr Radiol 2008; 38(Suppl 1): S18-S27.
162. Rohrschneider WK, Becker K, Hoffend J et al. Combined static-dynamic MR urography for the simultaneous evaluation of morphology and function in urinary tract obstruction. II. Findings in experimentally induced ureteric stenosis. Pediatr Radiol 2000; 30: 523-532.
163. Jones RA, Perez-Brayfield MR, Kirsch AJ et al. Renal transit time with MR urography in children. Radiology 2004; 233: 41-50.
164. Vivier PH, Blondiaux E, Dolores M et al. Functional MR urography in children. J Radiol 2009; 90: 11-19.